Welcome to LookChem.com Sign In|Join Free
  • or
(9alpha,13alpha,14alpha)-3-methoxymorphinan-17-carbaldehyde is a chemical compound belonging to the morphinan family, derived from morphine. It features a carbaldehyde and a methoxy group, contributing to its pharmacological properties. Known for its analgesic effects, (9alpha,13alpha,14alpha)-3-methoxymorphinan-17-carbaldehyde also holds potential in treating opioid addiction and dependence, and is significant in medicinal chemistry as a precursor for developing new pharmaceuticals targeting the opioid receptor system.

28973-48-0

Post Buying Request

28973-48-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

28973-48-0 Usage

Uses

Used in Pharmaceutical Industry:
(9alpha,13alpha,14alpha)-3-methoxymorphinan-17-carbaldehyde is used as an intermediate in the synthesis of opioid drugs for its role in creating compounds with analgesic properties. It is particularly instrumental in the production of drugs such as naloxone and naltrexone, which are vital in managing opioid overdose and addiction.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, (9alpha,13alpha,14alpha)-3-methoxymorphinan-17-carbaldehyde serves as a valuable precursor. It is utilized in the development of novel pharmaceuticals that target the opioid receptor system, potentially leading to the discovery of new treatments for pain management and opioid-related disorders.
Used in Pain Management:
(9alpha,13alpha,14alpha)-3-methoxymorphinan-17-carbaldehyde is used as an analgesic agent for its pain-relieving effects, providing an alternative or adjunct to existing treatments for various types of pain conditions.
Used in Opioid Addiction Treatment:
(9alpha,13alpha,14alpha)-3-methoxymorphinan-17-carbaldehyde is used in the development of medications aimed at treating opioid addiction and dependence, offering potential therapeutic benefits for individuals struggling with these conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 28973-48-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,8,9,7 and 3 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 28973-48:
(7*2)+(6*8)+(5*9)+(4*7)+(3*3)+(2*4)+(1*8)=160
160 % 10 = 0
So 28973-48-0 is a valid CAS Registry Number.

28973-48-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name N-Formyl Dextromethorphan

1.2 Other means of identification

Product number -
Other names EINECS 249-345-0

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:28973-48-0 SDS

28973-48-0Synthetic route

(S)-2-Formyl-1-<(4-methoxyphenyl)methyl>-1,2,3,4,5,6,7,8-octahydroispquinoline
29144-31-8

(S)-2-Formyl-1-<(4-methoxyphenyl)methyl>-1,2,3,4,5,6,7,8-octahydroispquinoline

(+)-3-methoxy-N-formylmorphinan
28973-48-0

(+)-3-methoxy-N-formylmorphinan

Conditions
ConditionsYield
With phosphoric acid In neat (no solvent) at 80℃; for 10h; Reagent/catalyst; Temperature; Time; Green chemistry;98%
dextromethorphan
125-71-3

dextromethorphan

B

(+)-3-methoxy-N-formylmorphinan
28973-48-0

(+)-3-methoxy-N-formylmorphinan

Conditions
ConditionsYield
With oxygen; lithium perchlorate; 9,10-Dicyanoanthracene In acetonitrile at 20℃; Irradiation;A 83 % Spectr.
B 10 % Spectr.
With oxygen; 9,10-Dicyanoanthracene In acetonitrile at 20℃; Irradiation;A 43 % Spectr.
B 57 % Spectr.
With potassium carbonate; tris(p-bromophenyl)aminium hexafluorophosphate In water; acetonitrile at -20℃; Solvent; Reagent/catalyst; Temperature; Inert atmosphere;
(+)-3-methoxymorphinan hydrochloride
36397-14-5

(+)-3-methoxymorphinan hydrochloride

formic acid ethyl ester
109-94-4

formic acid ethyl ester

(+)-3-methoxy-N-formylmorphinan
28973-48-0

(+)-3-methoxy-N-formylmorphinan

Conditions
ConditionsYield
With ammonium hydroxide; formic acid Heating; Yield given;
dextromethorphan hydrobromide

dextromethorphan hydrobromide

(+)-3-methoxy-N-formylmorphinan
28973-48-0

(+)-3-methoxy-N-formylmorphinan

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 90 percent / a.) 20percent aq. NH4OH, b.) K2CO3, 1-chloroethyl chloroformate / 1,2-dichloro-ethane / 6 h / Heating
2: a.) 20percent aq. NH4OH, b.) 100percent HCOOH / Heating
View Scheme
4-Methoxyphenylacetic acid
104-01-8

4-Methoxyphenylacetic acid

(+)-3-methoxy-N-formylmorphinan
28973-48-0

(+)-3-methoxy-N-formylmorphinan

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 5 h / 150 °C
2: POCl3 / benzene / Heating
3: pyridine; tetrahydrofuran / 8 h / 0 °C
4: H2 / Ru(OCOCF3)2<(S)-tolbinap> / methanol / 100 h / 30 °C / 76000.1 Torr
View Scheme
1-(4-methoxybenzyl)-3,4,5,6,7,8-hexahydro-isoquinoline
51072-35-6

1-(4-methoxybenzyl)-3,4,5,6,7,8-hexahydro-isoquinoline

(+)-3-methoxy-N-formylmorphinan
28973-48-0

(+)-3-methoxy-N-formylmorphinan

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: pyridine; tetrahydrofuran / 8 h / 0 °C
2: H2 / Ru(OCOCF3)2<(S)-tolbinap> / methanol / 100 h / 30 °C / 76000.1 Torr
View Scheme
N-(2-cyclohex-1-enylethyl)-2-(4-methoxyphenyl)-acetamide
51072-34-5

N-(2-cyclohex-1-enylethyl)-2-(4-methoxyphenyl)-acetamide

(+)-3-methoxy-N-formylmorphinan
28973-48-0

(+)-3-methoxy-N-formylmorphinan

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: POCl3 / benzene / Heating
2: pyridine; tetrahydrofuran / 8 h / 0 °C
3: H2 / Ru(OCOCF3)2<(S)-tolbinap> / methanol / 100 h / 30 °C / 76000.1 Torr
View Scheme
(Z)-2-Formyl-1-<(4-methoxyphenyl)methylene>-1,2,3,4,5,6,7,8-octahydroisoquinoline
116172-20-4

(Z)-2-Formyl-1-<(4-methoxyphenyl)methylene>-1,2,3,4,5,6,7,8-octahydroisoquinoline

(+)-3-methoxy-N-formylmorphinan
28973-48-0

(+)-3-methoxy-N-formylmorphinan

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: H2 / Ru(OCOCF3)2<(S)-tolbinap> / methanol / 100 h / 30 °C / 76000.1 Torr
View Scheme
2-(1-cyclohexenyl)ethylamine
3399-73-3

2-(1-cyclohexenyl)ethylamine

(+)-3-methoxy-N-formylmorphinan
28973-48-0

(+)-3-methoxy-N-formylmorphinan

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 5 h / 150 °C
2: POCl3 / benzene / Heating
3: pyridine; tetrahydrofuran / 8 h / 0 °C
4: H2 / Ru(OCOCF3)2<(S)-tolbinap> / methanol / 100 h / 30 °C / 76000.1 Torr
View Scheme
(-)-octabase mandelate salt

(-)-octabase mandelate salt

(+)-3-methoxy-N-formylmorphinan
28973-48-0

(+)-3-methoxy-N-formylmorphinan

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 48 h / Reflux
2: phosphoric acid / neat (no solvent) / 10 h / 80 °C / Green chemistry
View Scheme
dextromethorphan hydrobromide

dextromethorphan hydrobromide

B

(+)-3-methoxy-N-formylmorphinan
28973-48-0

(+)-3-methoxy-N-formylmorphinan

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: sodium hydroxide / water / pH 10 / Inert atmosphere
2: tris(p-bromophenyl)aminium hexafluorophosphate; potassium carbonate / acetonitrile; water / -20 °C / Inert atmosphere
View Scheme
(+)-3-methoxy-N-formylmorphinan
28973-48-0

(+)-3-methoxy-N-formylmorphinan

(+)-3-hydroxy-17-formylmorphinan
50300-00-0

(+)-3-hydroxy-17-formylmorphinan

Conditions
ConditionsYield
With boron tribromide In dichloromethane at 0℃; for 0.0833333h; Yield given;
(+)-3-methoxy-N-formylmorphinan
28973-48-0

(+)-3-methoxy-N-formylmorphinan

norlevorphanol
1531-12-0

norlevorphanol

Conditions
ConditionsYield
With hydrogen bromide for 5h; Heating;3.2 g
(+)-3-methoxy-N-formylmorphinan
28973-48-0

(+)-3-methoxy-N-formylmorphinan

dextromethorphan
125-71-3

dextromethorphan

(+)-3-methoxy-N-formylmorphinan
28973-48-0

(+)-3-methoxy-N-formylmorphinan

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 3.2 g / 48percent aq. HBr / 5 h / Heating
2: 1.) formic acid, 2.) 1 N methanolic NaOH / 1.) H2O, reflux, 5 h, 2.) reflux, 2 h
View Scheme
(+)-3-methoxy-N-formylmorphinan
28973-48-0

(+)-3-methoxy-N-formylmorphinan

C20H27NO2

C20H27NO2

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: BBr3 / CH2Cl2 / 0.08 h / 0 °C
2: K2CO3 / dimethylformamide / 60 °C
View Scheme
(+)-3-methoxy-N-formylmorphinan
28973-48-0

(+)-3-methoxy-N-formylmorphinan

(+)-3-(2-propoxy)-17-methylmorphinan
98985-26-3

(+)-3-(2-propoxy)-17-methylmorphinan

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: BBr3 / CH2Cl2 / 0.08 h / 0 °C
2: K2CO3 / dimethylformamide / 60 °C
3: LiAlH4 / tetrahydrofuran / 0.5 h / 0 °C
View Scheme
(+)-3-methoxy-N-formylmorphinan
28973-48-0

(+)-3-methoxy-N-formylmorphinan

(+)-3-methoxy-N-phenylacetylmorphinan

(+)-3-methoxy-N-phenylacetylmorphinan

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: sodium hydroxide / methanol / Reflux
2: sodium hydroxide / 0.17 h
View Scheme
(+)-3-methoxy-N-formylmorphinan
28973-48-0

(+)-3-methoxy-N-formylmorphinan

Conditions
ConditionsYield
With sodium hydroxide In methanol Reflux;

28973-48-0Relevant academic research and scientific papers

Contra-thermodynamic Hydrogen Atom Abstraction in the Selective C-H Functionalization of Trialkylamine N-CH3 Groups

Barham, Joshua P.,John, Matthew P.,Murphy, John A.

, p. 15482 - 15487 (2016/12/09)

We report a simple one-pot protocol that affords functionalization of N-CH3 groups in N-methyl-N,N-dialkylamines with high selectivity over N-CH2R or N-CHR2 groups. The radical cation DABCO+?, prepared in situ by oxidation of DABCO with a triarylaminium salt, effects highly selective and contra-thermodynamic C-H abstraction from N-CH3 groups. The intermediates that result react in situ with organometallic nucleophiles in a single pot, affording novel and highly selective homologation of N-CH3 groups. Chemoselectivity, scalability, and recyclability of reagents are demonstrated, and a mechanistic proposal is corroborated by computational and experimental results. The utility of the transformation is demonstrated in the late-stage site-selective functionalization of natural products and pharmaceuticals, allowing rapid derivatization for investigation of structure-activity relationships.

An improved process for the preparation of (+)-3- Methoxy-N-formylmorphinan

Kumaraguru, Thenkrishnan,Fadnavis, Nitin W.

, p. 174 - 178 (2014/05/20)

Two major steps, N-formylation of (-)-octabase and cyclization of the N-formylated product, involved in synthesis of (+)-3-methoxy-N-formylmorphinan, a key intermediate for production of dextromethorphan (DXM), have been improved to achieve higher yields in shorter time with fewer effluents. Methods of analysis of chemical and enantiomeric purities of the intermediates by HPLC and strategies for easy recovery and recycle of the reagents have been devised.

Dextrorphan. Note II. Preparation of dextrorphan citrate

Passarotti,Valenti,Grianti

, p. 475 - 477 (2007/10/02)

Preparation of destrorphan citrate, a very soluble salt in water, in described. This salt may be used in oral composition with anti-tussive activity. Structural date are reported about 1H-NMR, 13C-NMR, COSY.

Synthesis and Evaluation of 3-Substituted 17-Methylmorphinan Analogs as Potential Anticonvulsant Agents

Newman, Amy Hauck,Bevan, Kathryn,Bowery, Norman,Tortella, Frank C.

, p. 4135 - 4142 (2007/10/02)

Dextromethorphan (1, (+)-3-methoxy-17-methylmorphinan) demonstrates anticonvulsant activity in a variety of in vitro and in vivo models of convulsive action.It is well known that 1 is metabolized to its phenolic derivative dextrorphan (2) and this metabolite is also a potent anticonvulsant.A series of (+)-3-substituted-17-methylmorphinans, which are structurally similar to 1 but are either not expected to be metabolized to 2 or might do so at a reduced rate, as compared to 1, were prepared.Three analogs, 5 ((+)-3-amino-17-methylmorphinan), 14 ((+)-3-ethoxy-17-methylmorphinan), and 15 ((+)-3-(2-propoxy)-17-methylmorphinan were found to possess potent anticonvulsant activity with full efficacy (ED50 25, 5.6, and 3.9 mg/kg, sc, respectively) in the rat supramaximal electroshock (MES) test.Binding potencies of these compounds to receptor sites labeled with 3H>dextromethorphan (3H>1), in rat brain and guinea pig brain subcellular fractions, and 3H>thienylcyclohexylpiperidine (TCP) and 3H>glycine in rat brain, were determined.Most of the analogs displaced 3H>1 from its binding sites, with compounds 14 (IC50 0.42 μM) and 15 (IC50 0.88 μM having equivalent potencies to 1 (IC50 0.59 μM), in rat brain, and no appreciable activity at the 3H>TCP or 3H>glycine-labeled sites.Compound 5 did not bind with appreciable activity to the 3H>1 site, in rat brain, but did bind to the 3H>TCP site with lower potency than the parent 1 (IC50 7.8 and 2.0 μM, respectively).The mechanism of anticonvulsant action of these agents is not clear although it appears that interaction at the 3H>1 sites may be involved.

ELECTRON-TRANSFER ACTIVATION. SALT EFFECTS ON THE PHOTOOXADIDATION OF TERTIARY AMINES : A USEFUL N-DEMETHYLATION METHOD

Santamaria, J.,Ouchabane, R.,Rigaudy, J.

, p. 3977 - 3980 (2007/10/02)

Photooxidation of tertiary methylamines sensitized by electron acceptors like 9,10-dicyanoanthracene is shown to proceed by two distinct ways depending on the presence of added salts.In the absence of added salt both nor and N-formyl compounds were obtained while with added salt the nor-derivative is obtained highly efficiently.

GENERAL ASYMMETRIC SYNTHESIS OF BENZOMORPHANS AND MORPHINANS VIA ENANTIOSELECTIVE HYDROGENATION

Kitamura, M.,Hsiao, Yi,Noyori, R.,Takaya, H.

, p. 4829 - 4832 (2007/10/02)

A variety of optically active benzomorphans including metazocine and pentazocine as well as dextromethorphan, a morphinan, are obtainable by using the BINAP-ruthenium(II) catalyzed enantioselective hydrogenation as key operation.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 28973-48-0